Please enable Javascript to use all features and improve your user experience.
HUPO 2024
Program
Posters
People
Search
EN
Posters on the topic "Defining Signaling Networks - Functional PTMs"
Back
P-I-0001
Phosphoproteomic alterations in Mesenchymal stem cells induced by Dimethyl fumarate treatment
Maryam Adelipour (Daejeon / KR)
P-I-0002
Insights into phosphorylation post-translational modifications in the proteome of
C. albicans
during oxidative stress response
Víctor Arribas (Madrid / ES)
P-I-0003
Using phosphoproteomics to explore autophagy relevant TBK1 signal transduction
Ibrahim Bayramoglu (Fribourg / CH)
P-I-0004
Active oxidative metabolism and impaired glyoxalase system amid elevated intracellular oxidative stress in non-small cell lung cancer shown by immediate post surgery alkylation and redox proteomics
Ruth Birner-Grünberger (Vienna / AT; Graz / AT)
P-I-0005
Proteome-wide in vitro kinase and phosphatase assays to determine enzyme-substrate interactions
Melanie Brunner (Fribourg / CH)
P-I-0006
Proteomic and phosphoproteomic characterization of FFPE lung adenocarcinoma harboring ALK, EGFR or KRAS Mutations, and triple wild-type tissue sections
Fanni Bugyi (Budapest / HU)
P-I-0007
Functional phosphoproteomics and network models to elucidate mechanisms of deregulated signaling
Mira Lea Burtscher (Heidelberg / DE)
P-I-0008
Dissecting the spatiotemporal regulation of the cell cycle using phosphoproteomics and highlighting functional differences within proteoform families
Anthony Cesnik (Stanford, CA / US; Stockholm / SE; San Francisco, CA / US)
P-I-0009
Simultaneous profiling of sialoglycoproteome and phosphoproteome in TKI-resistant NCSLC cells using metal ion-decorated ZIC-cHILIC StageTip
Yi-Ju Chen (Taipei / TW)
P-I-0010
A multi-proteomics analysis of FGFR family mutations on cancer signalling networks
Iftekhar Mahmud Chowdhury (Helsinki / FI)
P-I-0011
Traceability of post-translational modifications in atherosclerosis from plasma to tissue to single-cell proteomics
David del Rio Aledo (Madrid / ES)
P-I-0012
Mass spectrometry analysis of post translational modification in adeno-associated virus capsid proteins
Vrushali Deshpande (Bangalore / IN)
P-I-0013
The regulatory role of CARP-NF-
κ
B in breast cancer metastasis
Penchatr Diskul Na Ayudthaya (Chungcheongnam-do / KR; Bangkok / TH)
P-I-0014
Light changes promote distinct responses of plastid protein acetylation marks in the model plant
Arabidopsis thaliana
Juergen Eirich (Muenster / DE)
P-I-0015
Effect of lysine post-translational modifications in the proteome of extracellular vesicles from non-small cell lung cancer cells
Sergio Manuel Encarnación-Guevara (Mexico City / MX)
P-I-0016
Exploring EGFR and MET cross-talk in NSCLC: a pathway to improved therapy efficacy
Dario Frey (Heidelberg / DE)
P-I-0017
Phosphotyrosine-based phosphoproteomics scaled down to sub-mg needle biopsy level for analysis of individual tumor biology and treatment selection
Alex Henneman (Amsterdam / NL)
P-I-0018
Deciphering the signaling mechanisms of the C-type lectin receptor Dectin-1 in myeloid cells using high throughput proteomics
Anne Gonzalez de Peredo (Toulouse / FR)
P-I-0019
Hydrogen sulfide signalling as an additional factor to sex-related differences in ALS progression
Viviana Greco (Rome / IT)
P-I-0020
A targeted proteomic approach to assess the presence of mouse-specific histone H3 variants in brain and testis
Hassan Hijazi (Grenoble / FR)
P-I-0021
Single-shot tyrosine phosphoproteomics through FAIMS-DIA, and FAIMS-PRM mass-spectrometry afterwards, in revealing the signaling networks associated with BTKi-mediated drug mechanism of action
Mahmud Hossain (Cambridge, MA / US)
P-I-0022
Redox proteome analysis of rat liver: gender-specific effects to diet and aging
Isabel Huber (Potsdam / DE)
P-I-0023
A pharmacological dimension to personalised phosphoproteomics of human skeletal muscle
Hannah Huckstep (Parkville / AU)
P-I-0024
Analysing non-proteinaceous ubiquitination via NoPro-clipping
Marco Jochem (Parkville / AU; Melbourne / AU)
P-I-0025
Accelerating single-shot phosphoproteomics by identification and quantitation of > 100,000 phosphosites in human cell lines
Claire Koenig (Copenhagen / DK)
P-I-0026
Comparison of phosphopeptide enrichment and LC-MS/MS acquisition methods to study cancer phosphoproteome
Petr Lapcik (Brno / CZ)
P-I-0027
Posttranslational modification of angiotensin II by pyridoxal-5'-phosphate as a new drug approach against high blood pressure
Michaela Lellig (Aachen / DE)
P-I-0028
Deciphering the role of ADP-ribosylation in CardioLaminopathy
Deena Leslie Pedrioli (Zurich / CH)
P-I-0029
Secretome and degradome analysis reveal effects of Kallikrein-related peptidase 6 on ECM arrangement and immune recognition in PDAC
Mujia Li (Freiburg / DE)
P-I-0030
SICyLIA-TMT: a multi-step labelling strategy for global redox proteomics
Sergio Lilla (Glasgow / GB)
P-I-0031
A dynamic interaction landscape of the mammalian Hh signaling pathway
Xiaonan Liu (Helsinki / FI)
P-I-0032
Delineating organ phosphoproteomic landscapes and deregulated metabolic associated signaling under dietary intervention
Ziliang Ma (Utrecht / NL; Singapore / SG)
P-I-0033
Comparative quantitative proteome and phosphoproteome analysis of castor bean (
Ricinus communis
L.) seed endosperm at different imbibition stages
Yara Martins da Silva (Rio de Janeiro / BR)
P-I-0034
The phosphoproteome of stress granules
Sophie Moggridge (Seattle, WA / US)
P-I-0035
Defining intracellular and extracellular role of AGR2: insights of from CRISPR-targeted breast cancer cells and DIA-NN analysis
M. Aiman Mohtar (Kuala Lumpur / MY)
P-I-0037
Comprehensive analysis of the redox proteome reveals survival pathways activated upon resistance to Pevonedistat
Michaela Myšáková (Prague / CZ)
P-I-0038
Proteomic characterization of the protein S-glutathionylation pattern in stem and leukemic cells
Dušan Němec (Vestec / CZ)
P-I-0039
PM2.5 engages impairment of mucosal immunity, involving alteration of complement activation and cell junction assembly by regulated IL-17 levels: Pathological and proteomic approaches
Warat Palpai (Samut Prakan / TH)
Thamradee Tansrivorarat (Samut Prakan / TH)
P-I-0040
Redox proteomics identifies a novel adaptive mechanism of leukemic cells emerging upon exposure to hypomethylation therapy
Kristýna Pimková (Vestec / CZ)
P-I-0041
Histone variants and post-translational modifications in the regulation of plant callus formation
Pavlína Pírek (Brno / CZ)
P-I-0042
Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing
Anastasia Piskopou (Utrecht / NL)
P-I-0043
Global, site-resolved analysis of ubiquitylation occupancy and turnover rate reveals systems properties
Gabriela Prus (Copenhagen / DK)
P-I-0044
Proteomic workflows for substrate screening and site mapping of ubiquitin-like protein modification
Elena Rudashevskaya (Goettingen / DE)
P-I-0045
Proteomic and phosphoproteomic profiling of a TRIB2-KO glioblastoma-derived cell line reveals new roles in cell signaling
Pablo San Segundo Acosta (Madrid / ES)
Rodrigo Barderas (Madrid / ES)
P-I-0046
Spike-in enhanced phosphoproteomics uncovers synergistic signaling responses to MEK inhibition in colon cancer cells
Matthias Selbach (Berlin / DE)
P-I-0047
Phosphoproteomic delineation of platelet activation states
Eva Smit (Amsterdam / NL)
P-I-0048
Multiproteomics approach reveals an axonogenesis and synaptogenesis disruption throughout congenital Zika syndrome progression
Patricia Sosa-Acosta (Rio de Janeiro / BR)
P-I-0049
Proteome-wide analysis of PTM-dependent protein conformational changes
Damiano Tosolini (Berlin / DE)
P-I-0050
Pitfalls in phosphoproteomic data analysis
Christine von Toerne (Munich / DE)
P-I-0051
Deep learning-assisted lactylprotein mining (DeepLaM) identifies potential pan-cancer biomarkers
Ning Wan (Nanjing / CN)
Hui Ye (Nanjing / CN)
P-I-0053
Quantitative phosphoproteomics identifies filamin C as a signaling hub of MAP kinases in skeletal muscle cells during acute mechanical stress
Johannes P. Zimmermann (Wuerzburg / DE)
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy